Daniel R. Rhodes, Ph.D., Interview at Molecular Targets and Cancer Therapeutics 2011
Dr. Rhodes discusses his strategy for identifying novel targets and for generating new opportunities for existing targeted therapies and the potential for ...
American Association for Cancer Research
René Bernards, Ph.D., Inverview at Molecular Targets and Cancer Therapeutics 2011
Interview with René Bernards, Ph.D., division head, molecular carcinogenesis, The Netherlands Cancer Institute at the AACR-NCI-EORTC International ...
American Association for Cancer Research
Gene Edited Cells: Next Generation of Cancer Therapeutics
Visit: http://www.uctv.tv) Khalid Shah, MS, PhD discusses translating biological therapies into clinical care. Series: "Stem Cell Channel" [Show ID: 34912]
University of California Television (UCTV)
William Pao, M.D., Ph.D., Interview at Molecular Targets and Cancer Therapeutics 2011
Interview with William Pao, M.D., Ph.D., Ingram associate professor of cancer research; director, division of hematology and oncology and personalized cancer ...
American Association for Cancer Research
A “key” discovery: Targeting DNA knots for cancer therapeutics | Caitlin Miron | TEDxQueensU
At least 85% of cancer cells take advantage of cellular processes controlled by unusual DNA “knots” known as guanine quadruplexes. Caitlin Miron, PhD ...
TEDx Talks
Alex Baker Engineered Viruses as Precision Cancer Therapeutics
Presented By: Alexander T. Baker, MSci (Hons), 1st Class - PhD Researcher Speaker Biography: Alex's research is in the nascent field of oncolytic virotherapy, ...
LabRoots
Immunotherapy vs. targeted therapy for cancer treatment
In this episode, Dr. David Hong explains how immunotherapy and targeted therapy work, how they are different and areas where the two overlap. Request an ...
MD Anderson Cancer Center
Breast Cancer Therapeutics
Here is a simple breakdown of the therapeutics behind breast cancer! Medical Disclaimer: I am not promoting or dissauding use of any medications. I am only ...
Ms RxGeek
Patient-Derived Xenografts for Cancer Therapeutics Development and Predictive Modeling
Patient-derived xenograft (PDX) tumor models retain much of the biological diversity and heterogeneity of the original patient tumor. Recent advances in the ...
GENNews
Breast cancer - causes, symptoms, diagnosis, treatment, pathology
What is breast cancer? Breast cancer, or breast carcinoma, is an uncontrolled growth of epithelial cells within the breast. Find our complete video library only on ...
Osmosis
Trachette Jackson: Mathematical modeling of targeted cancer therapeutics
Increased understanding of the molecular drivers of tumor initiation and progression has led to targeted manipulation of intracellular signaling pathways for ...
Centre International de Rencontres Mathématiques
Introduction to Cancer Biology (Part 1): Abnormal Signal Transduction
This animation is the first part of the series "An Introduction to Cancer Biology", and explains the mechanism of abnormal signal transduction resulting in ...
Mechanisms in Medicine
Defining the Spectrum of Resistance to be Targeted Anti-Cancer Therapeutics
Air date: Wednesday, September 05, 2012, 3:00:00 PM Category: Wednesday Afternoon Lectures Description: Dr. Levi Garraway has made seminal research ...
NIH VideoCast
Cancer Metabolism: From molecules to medicine
It takes years to discover and develop a new medication. But what does this long-term, complicated process actually involve? In this seminar, Harvard Medical ...
Harvard Medical School
Cure Forward: The Promise of Personalized Cancer Therapeutics
Apologies for the bad audio - GoToWebinar recording software is beyond poor ** Join Cure Forward founder Martin Naley as he discusses their new program for ...
Ocular Melanoma Foundation
What is the latest development in cancer therapeutics?
Dr. Carl Morrison discusses the impact of immuontherapy on cancer care and its potential to transform how we treat patients.
OmniSeq
Ross Cagan - Embracing Complexity Drosophila as a Tool to Develop Cancer Therapeutics
Watch on LabRoots at: http://labroots.com/user/webinars/details/id/90 Cancer and diabetes are complex diseases that have proven difficult to treat in the clinics.
LabRoots
Tina Lockwood - Clinical next generation sequencing for precision cancer therapeutics
Watch on LabRoots at http://labroots.com/webcast/id/657 Next-generation sequencing has emerged as a valuable tool for generating patient-specific genetic ...
LabRoots
Immune Checkpoint Blockade in Cancer Therapy
UC Berkeley Events
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
Dr Neal Shore speaks to Prof Karim Fizazi about the changing landscape of treatments for prostate cancer, discussing immunotherapies, PARP inhibitors and ...
ecancer
modENCODE as Part of a Drosophila Search for Cancer Therapeutics - Ross Cagan
June 20-21, 2012 - Genomics of model organisms and human biology: Insights from the modENCODE Project More: http://www.genome.gov/27549319.
National Human Genome Research Institute
Dr. Alex Adjei Discusses the Evolution of Cancer Therapeutics
Alex A. Adjei, MD, PhD, Professor and Chair, Department of Medicine, Katherine Anne Gioia Chair in Cancer Medicine, Senior Vice President, Clinical Research ...
Targeted Oncology
Ramot Virtual Round Table Cancer Therapeutics and Diagnostics 2020
Prof. Ronit Satchi-Fainaro: ComBiMiP: Combined anti-cancer nano-therapy for treatment and prevention of residual disease post-image-guided excision Prof.
Ramot at TAU
Thyroid Cancer: Complexity, Results at Center for Personalized Cancer Therapeutics. Dr. Smibert.
Complexity in Thyroid Cancer: Recent Research Results and Studies at the Center for Personalized Cancer Therapeutics. Peter Smibert, Ph.D., Regenerative ...
ThyCa: Thyroid Cancer Survivors' Association, Inc.
From epigenetic mechanisms to cancer therapeutics
At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Stephen Nimer, MD, from Memorial Sloan-Kettering Cancer Center, New York, ...
VJHemOnc – Video Journal of Hematological Oncology
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets
In this presentation from the 14th Annual Best of San Antonio - Breast Cancer: Bench to Bedside, Dr. Debu Tripathy discusses novel therapeutics for the ...
ImedexCME
SMAC Mimetics: A New Class of Cancer Therapeutics
Smac mimetics are a new class of targeted drugs being developed for the treatment of solid tumours and hematologic cancers. Smac mimetics specifically ...
Drug Discovery World
How molecular therapeutics have changed the role of radiology in lung cancer care
Gerhad Mostbeck, MD of the Otto Wagner Hospital, Vienna, Austria talks about how the aims of radiology in patients with lung cancer have completely changed ...
VJOncology
Nanoparticle drug delivery in cancer therapy
Nanobotmodels Company presents vision of modern drug delivery methods using DNA-origami nanoparticles. In animation you can see cancer therapy using ...
Nanobot Medical Animation Studio
NANOGAP Therapeutics developing 'widely applicable' cancer treatment
NANOGAP Therapeutics CEO Ross Breckenridge joined Proactive Investors at the 11th Annual BioTech Showcase in San Francisco. The company is a seed ...
Proactive
Multi-Tensor Decompositions for Personalized Cancer Diagnostics, Prognostics, and Therapeutics
Join this webinar to learn about the development of novel, multi-tensor generalizations of the singular value decomposition and their use in the comparisons of ...
Amazon Web Services
Precision Therapy Based on a Molecular Platform for RNAi Therapeutics
Prof. Dr. Dan Peer, Chair, Tel Aviv University Cancer Biology Research Center, Director, Center for Translational Medicine, Director, Laboratory of Precision ...
TAUVOD
Molecular Screening and Therapeutics (MoST) Program Explained
The Molecular Screening and Therapeutics (MoST) clinical trials are independent of where cancer arises in the body, as MoST personalise experimental ...
Rare Cancers Australia
Exiqon Webinar: lncRNAs advancing therapeutics for cancer and heart disease
Hear the authors of two high impact papers in Nature and Science Translational Medicine describe how long non-coding RNAs provide new therapeutic ...
Exiqon
Molecular diagnostics & therapeutics
The AML Hub are pleased to be covering the European School of Haematology (ESH) 2nd How to Diagnose and Treat: Acute Leukaemia meeting. Here, we ...
AML Hub
Plenary Session: Panel Discussion on Potential of AYUSH systems in Cancer therapeutics
INTERNATIONAL CONFERENCE AYUSH for Future Health Challenges: Strengthening Trans-Disciplinary Research Organised by AYUSH Center of Excellence ...
Center for Complementary and Integrative Health
Juno Therapeutics on how it plans to kill cancer
Dr. Phil Greenberg, founding scientist of Juno Therapeutics, talks about what the new startup is doing to revolutionize cancer treatment.
GeekWire
Non Small Cell Lung Cancer Therapeutics in Asia Pacific Markets
Non-Small Cell Lung Cancer (NSCLC) is the most common cancer and cause of cancer-related mortality globally. There were more than 1.8 million newly ...
Shree Ghuge
Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit
In this presentation from the 14th Annual Best of San Antonio - Breast Cancer: Bench to Bedside, Dr. Kathy S. Albain discusses updates in adjuvant and ...
ImedexCME
Kazia Therapeutics developing unique drug to battle brain cancer
Kazia Therapeutics Limited (NASDAQ:KZIA)(ASX:KZA) CEO James Garner sat down with Christine Corrado from Proactive Investors at the 11th Annual Biotech ...
Proactive
Sensory Illusion Causes Cells to Self-Destruct
Yeast cells' normal protective response to a mild stressor gets massively amplified by an unnatural oscillating pattern of stress, causing the yeast colony to ...
UC San Francisco (UCSF)
How targeted therapies work – Macmillan Cancer Support
This cancer information video describes a common treatment for cancer – targeted therapies. The animation shows how the targeted therapies work and what ...
Macmillan Cancer Support
